Healthcare provider profile · identity verified

Sean Benjamin Neller, DO

Internal Medicine · IRVING, TX · NPI 1255866844

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	571	215
Amlodipine Besylate	Amlodipine Besylate	302	104
Levothyroxine Sodium	Levothyroxine Sodium	249	86
Metformin Hcl	Metformin Hcl	235	87
Lisinopril	Lisinopril	224	97
Pantoprazole Sodium	Pantoprazole Sodium	217	89
Albuterol Sulfate Hfa	Albuterol Sulfate	211	61
Rosuvastatin Calcium	Rosuvastatin Calcium	202	74
Losartan Potassium	Losartan Potassium	184	65
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	162	76
Gabapentin	Gabapentin	150	56
Hydrochlorothiazide	Hydrochlorothiazide	140	49
Simvastatin	Simvastatin	132	56
Trazodone Hcl	Trazodone Hcl	130	46
Fluticasone Propionate	Fluticasone Propionate	128	55
Furosemide	Furosemide	122	53
Metformin Hcl Er	Metformin Hcl	111	39
Omeprazole	Omeprazole	105	42
Pioglitazone Hcl	Pioglitazone Hcl	104	43
Alendronate Sodium	Alendronate Sodium	103	37
Escitalopram Oxalate	Escitalopram Oxalate	103	43
Tamsulosin Hcl	Tamsulosin Hcl	103	42
Metoprolol Succinate	Metoprolol Succinate	98	39
Carvedilol	Carvedilol	93	36
Eliquis	Apixaban	92	26
Metoprolol Tartrate	Metoprolol Tartrate	91	30
Jardiance	Empagliflozin	89	33
Olmesartan Medoxomil	Olmesartan Medoxomil	88	33
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	87	13
Mounjaro	Tirzepatide	86	18
Allopurinol	Allopurinol	72	22
Tramadol Hcl	Tramadol Hcl	72	28
Symbicort	Budesonide/Formoterol Fumarate	70	13
Azelastine Hcl	Azelastine Hcl	69	33
Pravastatin Sodium	Pravastatin Sodium	69	29
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	63	21
Alprazolam	Alprazolam	62	15
Clopidogrel	Clopidogrel Bisulfate	60	23
Finasteride	Finasteride	57	20
Vitamin D2	Ergocalciferol (Vitamin D2)	57	22
Montelukast Sodium	Montelukast Sodium	56	21
Ozempic	Semaglutide	55	suppressed
Azithromycin	Azithromycin	53	44
Methocarbamol	Methocarbamol	52	30
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	51	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	44
Triamcinolone Acetonide	Triamcinolone Acetonide	47	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	15
Donepezil Hcl	Donepezil Hcl	40	17
Hydroxyzine Hcl	Hydroxyzine Hcl	40	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	33
Atenolol	Atenolol	39	14
Glipizide	Glipizide	39	23
Sertraline Hcl	Sertraline Hcl	39	14
Doxycycline Monohydrate	Doxycycline Monohydrate	37	29
Myrbetriq	Mirabegron	36	11
Duloxetine Hcl	Duloxetine Hcl	35	16
Mirtazapine	Mirtazapine	35	14
Nystatin	Nystatin	34	13
Buspirone Hcl	Buspirone Hcl	33	12
Famotidine	Famotidine	33	15
Nifedipine Er	Nifedipine	33	12
Potassium Chloride	Potassium Chloride	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	15
Ramipril	Ramipril	32	11
Bupropion Xl	Bupropion Hcl	31	14
Citalopram Hbr	Citalopram Hydrobromide	30	11
Hydralazine Hcl	Hydralazine Hcl	30	11
Tresiba Flextouch U-200	Insulin Degludec	30	suppressed
Spironolactone	Spironolactone	29	11
Ondansetron Hcl	Ondansetron Hcl	28	12
Enalapril Maleate	Enalapril Maleate	27	11
Mupirocin	Mupirocin	27	17
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	26	11
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Celecoxib	Celecoxib	23	15
Clotrimazole	Clotrimazole	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Meloxicam	Meloxicam	23	18
Prednisone	Prednisone	23	19
Lorazepam	Lorazepam	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Fluconazole	Fluconazole	21	14
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	12
Nitroglycerin	Nitroglycerin	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Methylprednisolone	Methylprednisolone	19	15
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	11
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Serevent Diskus	Salmeterol Xinafoate	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lactulose	Lactulose	17	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Valsartan	Valsartan	17	suppressed
Estradiol	Estradiol	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Amoxicillin	Amoxicillin	14	11
Bydureon Bcise	Exenatide Microspheres	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	12
Trulicity	Dulaglutide	12	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error